Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy. - Wikidata - awgldk - TriplyDB

Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy.

Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy.

http://www.wikidata.org/entity/Q42985583

about

Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.Pharmacological evaluation of novel 5-HT3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery Does pharmacogenomics account for variability in control of acute chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists?Genetic factors associated with pharmacotherapy and background sensitivity to postoperative and chemotherapy-induced nausea and vomiting.Pharmacogenetics of chemotherapy-induced nausea and vomiting.Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy.The Human Serotonin Type 3 Receptor Gene (HTR3A-E) Allelic Variant Database.A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting.

P2860

Q33992722-F163BF0C-DA71-4B1F-BEB9-CC75A0BA9AB5 Q35439123-F5FEE066-DF92-4F21-BAB4-43350B804C28 Q36816419-67E77749-7E4D-4142-913A-096199E932FE Q38209001-261B11F6-0A38-4168-8DAD-0C3983215301 Q38330216-F7024945-3E31-456F-8D7A-177D0C79D09B Q47572599-549FC0A0-C6C8-41E3-AE9D-D314E3279532 Q47855566-490C7FF0-FE51-46F0-AD4F-5556001B31A3 Q49570044-C09BD145-31F1-439D-8736-671FD379BD68

P2860

Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy.

http://www.wikidata.org/entity/Q42985583

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Polymorphism in HTR3D shows di ...... er anthracycline chemotherapy.

@en

Polymorphism in HTR3D shows di ...... er anthracycline chemotherapy.

@nl

type

label

Polymorphism in HTR3D shows di ...... er anthracycline chemotherapy.

@en

Polymorphism in HTR3D shows di ...... er anthracycline chemotherapy.

@nl

prefLabel

Polymorphism in HTR3D shows di ...... er anthracycline chemotherapy.

@en

Polymorphism in HTR3D shows di ...... er anthracycline chemotherapy.

@nl

P1433

Q42985583-4944CF7B-7ABF-457B-B79E-63618DA28FC7

P1476

Q42985583-C86C2670-7260-4ECF-8E6A-73666BBE3135

P2093

Q42985583-0A10CB01-3909-4F40-934C-549E4B44434D

Q42985583-242D6563-9D51-493E-914C-F829D9A61D38

Q42985583-3515D9F7-1E10-467B-8A1A-B1FE8D06108D

Q42985583-737E39F5-DEB8-4686-99D1-6E89DCF25A88

Q42985583-CB8768D4-EE65-4ED7-B9A3-BB2A62AF0431

Q42985583-E2255097-AF29-4758-8E15-17E607637E30

Q42985583-F8970C9C-83BD-4FF5-87DE-E9E998D6596A

P2860

Q42985583-0B7A71D1-C35F-4CC9-85D3-BCF604DF2280

Q42985583-0BB7CBAC-BD5F-422D-8C7D-2BF3EA076291

Q42985583-18F1689B-E928-466C-8676-DF67CA13FE85

Q42985583-1D9AA688-1282-4AAA-AD81-931DFDD8D425

Q42985583-1F0776B9-E804-4589-9440-F29898F1CB7A

Q42985583-48264A51-E038-438F-8CFD-2293334EDF19

Q42985583-4B07D193-6FC2-4C67-9D2A-DAD3EE9C41F9

Q42985583-4FB15BCB-AD01-45B3-BD56-2552EC021E11

Q42985583-54903B1B-B4B6-4EB9-BD16-7FE3BCC73FAA

Q42985583-579AA231-1131-4159-A6A0-ABE2D187C136

P304

Q42985583-225B7379-A1FE-4ECA-9268-CB1511E1EDD2

P31

Q42985583-08EB4DE3-E8A9-4D6B-86A2-E5563D813F33

P356

Q42985583-03EAB564-65A0-455E-995E-7F01ED19C2A5

P433

Q42985583-7C52A04E-00D4-44C8-9A85-9EB9A308100E

P478

Q42985583-683D7F9C-B19D-4CCF-BC18-0A042DE37E4F

P50

Q42985583-0AFADF18-AA84-43D1-9ED7-B2538CBC2611

Q42985583-C1C26A5A-C0B5-4917-B0FA-280F82FC7E39

Q42985583-E279E3AF-A0F6-4CA2-9B93-3FBE165E651A

P577

Q42985583-963BF3CC-3359-4B0F-96C5-05557E24B455

P698

Q42985583-5817592D-D629-418A-9248-1F947CE96235

P921

Q42985583-38BA0680-7EF3-49DD-BC55-A612A90D071A

P356

P1433

Pharmacogenomics

P1476

Polymorphism in HTR3D shows di ...... er anthracycline chemotherapy.

@en

P2093

Beate Niesler

http://www.w3.org/2001/XMLSchema#string

Christian Hammer

http://www.w3.org/2001/XMLSchema#string

Christian R Loehberg

http://www.w3.org/2001/XMLSchema#string

Claudia Rauh

http://www.w3.org/2001/XMLSchema#string

Mayada R Bani

http://www.w3.org/2001/XMLSchema#string

Reiner Strick

http://www.w3.org/2001/XMLSchema#string

Sebastian M Jud

http://www.w3.org/2001/XMLSchema#string

P2860

The 5-HT3B subunit is a major determinant of serotonin-receptor function

Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E

Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods

A nomenclature for ligand-gated ion channels

PLINK: a tool set for whole-genome association and population-based linkage analyses

The structure of haplotype blocks in the human genome

Haploview: analysis and visualization of LD and haplotype maps

Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients.

Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E.

Association between the 5' UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder.

P304

943-950

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.10.67

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Peter A. Fasching

Matthias W. Beckmann

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20602613

http://www.w3.org/2001/XMLSchema#string

P921